American Green Wins 5 Year Cannabis Grow Management Contract from Curaleaf
PHOENIX– Today, American Green, Inc. (ERBB:OTC) announced that it has a new management services agreement with Curaleaf’s two cultivation facilities in Arizona. Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is an international provider of consumer products in cannabis which serves medical and adult-use customers throughout the state. This agreement will provide American Green with approximately $2.1 million dollars in annual revenue and $10.4 million in revenue over the term of the agreement.
David G. Gwyther, American Green’s president said “We are proud to extend our relationship with Curaleaf Holdings, Inc. for five years. There is also an opportunity for American Green to continue the agreement for three additional five-year periods after our initial five-year term is up. We will continue to provide our premium cannabis grown at our “Sweet Virginia” grow and provide the quality customer service that Curaleaf has been accustomed to so we can earn those future agreement extensions.”
“American Green has been a great partner to us and we are looking forward to continuing our relationship with them over the next five years,” said Steve Cottrell, president of Curaleaf Arizona.
American Green’s premium cannabis is used in various Curaleaf and Select products, including some of their popular Live Resin offerings.
NOTES ABOUT FORWARD-LOOKING STATEMENTS
Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company’s Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, be should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
(This information is primarily sourced from American Green, Inc. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...